Archived
Click for more details…….
The First Academic Entrepreneur-Investor Forum Indiana Center for Biomedical Innovation (ICBI) is hosting the “Entrepreneur-Investor Forum” on October 16th, 2018. The goal of the event is to bring together the key organizations involved in life sciences entrepreneurial ecosystem in Indianapolis and catalyze collaboration to promote commercialization of life science technologies. The event will be organized in partnership … Read more
HB Therapeutics Joins ICBI, Received NIH/NCI SBIR Phage I Grant
ICBI welcomes HB Therapeutic, Inc., which just received the NIH/NCI SBIR phase I grant of $300,000 for development of the company first small molecule degraders of small ubiquitin-like modifier-1 protein (SUMO1) as new anticancer drugs. Founded by Dr. Bellail and Dr. Hao in 2015, HB Therapeutics is a biotech company for discovery and development of … Read more
ICBI Company Vascugen Licenses Stem Cell Technology for Blood Vessel Regeneration, Raises $635K
INDIANAPOLIS, May 1, 2018 — Vascugen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University (IU) School of Medicine related to blood vessel formation from adult stem cells. The regenerative medicine company is focused on finding therapies to repair tissues damaged by reduced blood flow due to … Read more
ICBI Company Scioto Biosciences Closes $1.8M in Series A Financing, Receives Grants to Support Launch of New Microbiome Platform Technology
Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced it has closed on $1.8M in Series A financing to support the launch of its new microbiome platform technology. The funding represents a first-time interstate collaboration between two Indiana-based investors, BioCrossroads and Elevate Ventures, together with Ohio-based Rev1 Ventures, and follows … Read more
Technology Forum by Meso Scale Discovery
Technology seminar by Meso Scale Discovery (MSD), January 17th, 12:30-1:30 pm at the Indiana Center for Biomedical Innovation (ICBI). MSD provides singleplex and multiplexed assays for neurodegenerative, metabolic inflammation, oncology, toxicology, cell signaling and a broad range of other disease-focused biomarkers. It is also an open platform with necessary tools to help develop assays for … Read more
Invention to Startup Forum at ICBI: February 23rd at 12:30pm
Invention to Startup forum presentation by Femtera Laboratories LLC (ICBI startup company), developing cancer biomarkers using metabolomics. Title of the Talk: Metabolomics: on the way towards practical clinical application Friday, February 23rd, at 12:30pm at the Indiana Center for Biomedical Innovation (ICBI).
Entrepreneurial Accelerator Branches to Indiana_7 wks_ accelerator _program
gener8tor a nationally ranked accelerator has branched to Indiana, plans to offer seven-week program to five Indianapolis startups at the end of April. gBETA program is free, seven-week accelerator for early-stage companies. Each program is capped at five teams, and requires no fees and no equity. The program dates are April 26th – June … Read more
Allinaire Therapeutics Receives Significant Funding
Allinaire Therapeutics, a respiratory therapeutics start-up launched by BioMotiv, has recently received new investments from BioCrossroads’ Indiana Seed Fund and Indiana University’s Innovate Indiana Fund. The Funding will advance the development of therapeutics for the treatment of chronic obstructive pulmonary disorder (COPD) and other respiratory diseases. Read Now